Example: Heart Attack

Search clinical trials for: machine-learning algorithm

Total 10000 results

NCT05085366

Terminated

A Study to Evaluate the Efficacy, Safety, and Immunogenicity of mRNA-1647 Cytomegalovirus (CMV) Vaccine in Healthy Participants 16 to 40 Years of Age

Cytomegalovirus Infection
NCT00870649

Completed

Efficacy of Bilhvax in Association With Praziquantel for Prevention of Clinical Recurrences of Schistosoma Haematobium (Bilhvax3)

Urinary Schistosomiasis | Schistosoma Haematobium
NCT06099652

Completed

Evaluation of 611 in Chinese Adults With Moderate to Severe Chronic Obstructive Pulmonary Disease

Pulmonary Disease, Chronic Obstructive
NCT05929651

Completed

Study of Immunogenicity and Safety of MenQuadfi® as a Booster Vaccine in Toddlers 12 to 23 Months, Regardless of the Quadrivalent Meningococcal Conjugate Vaccine Used for Priming in Infancy

Healthy Volunteers | Meningococcal Immunisation
NCT04566484

Terminated

Seamless Controlled Trial To Evaluate Safety And Immunogenicity of Chikungunya Vaccine in LatinAmerica and Asia (IVICHIK001)

Chikungunya
NCT05154578

Completed

Immunogenicity and Safety of GBS-NN/NN2 in Pregnant Women

Group B Streptococcal Infection
NCT05035238

Withdrawn

Evaluation of the Efficacy, Safety and Immunogenicity of Inactivated COVID 19 Vaccine(TURKOVAC) in Healthy Population of 18 and 64 Years of Age (Both Inclusive):a Randomized, Double-blind, Phase IIb Clinical Trial

Covid19
NCT05242432

Terminated

A Study of Adenovirus Serotype 26.Respiratory Syncytial Virus.Pre-Fusion F (Ad26.RSV.preF)-Based Vaccine for Prevention of Respiratory Syncytial Virus (RSV) Mediated- Lower Respiratory Tract Disease (LRTD) in Japanese Participants

Respiratory Syncytial Virus Prevention
NCT05904054

Completed

Immunogenicity and Safety Study of SARS-CoV-2 DNA Vaccine (ICCOV)

COVID-19
NCT05290792

Completed

Use of Wearable Sensors for Early Detection and Tracking of Viral Respiratory Tract Infections (WE SENSE)

Influenza | Viral Respiratory Tract Infection
NCT06041867

Completed

Agaricus Bisporus and Influenza Vaccination Response

Immune Response
NCT04415424

Active, not recruiting

Efficacy Study of 4CMenB (Bexsero®) to Prevent Gonorrhoea Infection in Gay and Bisexual Men (GoGoVax)

Neisseria Gonorrheae Infection
NCT05571800

Completed

Effect of Mango Consumption on Individuals with Pre-diabetes

Obesity | PreDiabetes
NCT06692465

Completed

To Evaluate the Efficacy and Safety of GT20029 Solution in the Treatment of Androgenetic Alopecia (AGA) in Chinese Adult Males

Alopecia | Male Pattern Hair Loss
NCT05724472

Completed

Evaluation of Safety and Immunogenicity of rVSVΔG-SEBOV-GP Vaccine in Adults With Good General Health

Ebola Sudan Virus Disease
NCT03014310

Completed

H5N8 Mix and Match With or Without AS03 or MF59 in Healthy Adults: Immunology

Avian Influenza
NCT05031468

Completed

Multisite Observational Maternal and Infant Study for COVID-19 (MOMI-Vax)

COVID-19
NCT00119067

Completed

Anthrax Vaccine Clinical Trial to Assess Dose Reduction and Route Change (AVRP)

Healthy
NCT05945498

Completed

Evaluation of ТВ/Flu-05Е Vaccine for the Prevention of Tuberculosis Infection in BCG-vaccinated Volunteers Aged 18-50 Years

Tuberculosis Infection
NCT05142514

Completed

Safety and Immunogenicity of Recombinant Protein RBD Fusion Dimer Vaccine Against the Virus That Cause COVID-19, Known as Severe Acute Respiratoy Syndrome Coronavirus 2 (SARS-CoV-2)

COVID-19 | SARS-CoV-2 Acute Respiratory Disease
NCT04456595

Completed

Clinical Trial of Efficacy and Safety of Sinovac's Adsorbed COVID-19 (Inactivated) Vaccine in Healthcare Professionals (PROFISCOV)

COVID-19
NCT03629080

Completed

A Study of CMV Vaccine (HB-101) in Kidney Transplant Patients

Kidney Transplantation | Cytomegalovirus (CMV) Infection
NCT04220515

Completed

Inactivated Poliomyelitis Vaccine Made From Sabin Strain

Poliomyelitis
NCT05161845

Completed

Clinical Trial of Measles, Mumps and Rubella Combined Vaccine, Live

Vaccine | Immunotoxicity
NCT05609045

Withdrawn

A Phase 1, Randomised, Double-blinded, Placebo-controlled, Dose-escalation Study to Evaluate the Safety and Immunogenicity of RH109 as Booster

COVID-19 Pandemic
NCT05857176

Completed

Assessment of Safety and Satisfaction Toward COVID-19 Vaccines.

COVID-19 Vaccine Adverse Reaction
NCT04032093

Completed

A PHASE 2B PLACEBO-CONTROLLED, RANDOMIZED STUDY OF A RESPIRATORY SYNCYTIAL VIRUS (RSV) VACCINE IN PREGNANT WOMEN

Respiratory Tract Infection
NCT04192500

Completed

Safety and Immune Response of One Dose of OVX836 at Two Dose Levels, in Comparison to Influvac TetraTM, After Intramuscular Administration in Healthy Subjects Aged 18-65 Years

Influenza
NCT04090658

Completed

A Study to Test GlaxoSmithKline's (GSK) Respiratory Syncytial Virus RSV Candidate Vaccine's Safety and Immune Response in Japanese Older Adults

Respiratory Syncytial Virus Infections
NCT05107479

Completed

Effectiveness of Interactive Voice Response for COVID-19 Vaccination Training in the Democratic Republic of the Congo

COVID-19 Vaccine Knowledge | COVID-19 Vaccine Beliefs
NCT01034254

Completed

Field Trial of Maternal Influenza Immunization in Asia (Mothers'Gift)

Influenza Human
NCT05057936

Completed

Antibody After COVID-19 Vaccination

Covid19 | CKD | Breakthrough Infection | Kidney Transplant | Vaccination
NCT05150392

Completed

An Open-labelled Clinical Trial of Live Attenuated Varicella Vaccines to Evaluate the Immunity Persistence After Primary Immunization and Safety and Immunogenicity After the Booster Immunization

Varicella
NCT00000866

Completed

A Multicenter, Randomized, Placebo-Controlled, Double-Blind Trial to Evaluate the Safety and Immunogenicity of the Therion Recombinant Vaccinia-HIV-1 IIIB ENV/GAG/POL Vaccine (TCB-3B) and MN RGP 120/HIV-1 In Alum.

HIV Infections
NCT01376726

Completed

Evaluating the Safety and Immune Response to an HIV Vaccine in Healthy, HIV-Uninfected Adults Who Have Participated in Previous HIV Vaccine Clinical Trials and in Adults Who Have Not Participated in Previous HIV Vaccine Clinical Trials

HIV Infections
NCT03903926

Completed

Efficacy Trial of a Commercial EV71 Vaccine

Hand, Foot and Mouth Disease
NCT04789356

Active, not recruiting

Effectiveness of the Adsorbed Vaccine COVID-19 (Coronavac) Among Education and Public Safety Workers With Risk Factors for Severity (COVACMANAUS)

Covid19
NCT04430907

Withdrawn

HPV Vaccine in Postpartum Women

HPV Infection
NCT02968420

Completed

Long Term Immune Memory Responses to HPV Vaccination Following 2 vs 3 Doses of Quad-HPV Vaccine (Merck08)

Human Papillomavirus
NCT03704519

Completed

Imaging Study to Compare Effects of Darolutamide and Enzalutamide With Respect to Placebo on the Blood Flow in the Brain in Healthy Male Volunteers.

Cerebrovascular Circulation
NCT03165617

Completed

Clinical Study to Evaluate the Efficacy, Safety and Immunogenicity of QIVc in Subjects ≥2 to <18 Years of Age

Influenza, Human
NCT04568785

Completed

Effectiveness of a Brief Intervention for Acceptance of Influenza Vaccine in the Primary Care Setting

Health Education | Influenza Vaccination
NCT00809250

Completed

Vaccination With GM-K562 Cells in Patients With Advanced Myelodysplastic Syndrome (MDS) or Acute Myeloid Leukemia (AML) After Allogeneic Hematopoetic Stem Cell Transplantation

Acute Myeloid Leukemia | Chronic Myelomonocytic Leukemia | Myelodysplastic Syndrome-Refractory Anemia With Excess Blasts
NCT02111512

Completed

Safety of Nasal Influenza Immunisation in Egg Allergic Children - The SNIFFLE 2 Study (SNIFFLE-2)

Egg Hypersensitivity
NCT02718391

Terminated

Complementary Vaccination With Dendritic Cells Pulsed With Autologous Tumor Lysate in Resected Stage III and IV Melanoma Patients. (ACDC)

Malignant Melanoma | Adjuvant Drug Therapy | Vaccin Therapy
NCT03088904

Completed

Genetic and Environmental Factors in the Response to Influenza Vaccination (SLVP028)

Healthy | Influenza
NCT00325156

Completed

Assess the Safety & Reactogenicity of DTPa-IPV/Hib Vaccine Administered at 3, 4, 5 & 18 Mths of Age, in Healthy Infants

Tetanus | Diphtheria | Acellular Pertussis | Poliomyelitis | Haemophilus Influenzae Type b | Diphtheria-Tetanus-aPertussis-Poliomyelitis Vaccines
NCT01698346

Completed

Pertussis (Tdap) Vaccination in Pregnancy

Pertussis | Pregnancy
NCT02637557

Completed

A Trial of IW-3718 for 8 Weeks in Patients With Symptomatic Gastroesophageal Reflux Disease (GERD)

Gastroesophageal Reflux Disease
NCT01959165

Completed

MEDI7183 Phase 2 Study in Japanese Ulcerative Colitis Patients

Ulcerative Colitis

Search clinical trials for: machine-learning algorithm

Sponsors and Collaborators

Medical Conditions

Drug Interventions

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations